The accumulation of aggregated β-amyloid and tau proteins into plaques and tangles is a central feature of Alzheimer disease (AD). While plaque and tangle accumulation likely contributes to neuron and synapse loss, disease-related changes to oligodendrocytes and myelin are also suspected of playing a role in development of AD dementia. Still, to our knowledge, little is known about AD-related myelin changes, and even when present, they are often regarded as secondary to concomitant arteriosclerosis or related to aging.
T he progression of Alzheimer disease (AD) pathology occurs several years before the development of dementia. According to the amyloid-cascade hypothesis, the disruption of critical metabolic processes that lead to the ultimate neurodegeneration in AD is initiated by the accumulation of aggregated β-amyloid and the assembly of neurofibrillary tangles. 1 Such processes are clearly detrimental to neuronal cell bodies, dendrites, and axonal processes; however, myelin and myelin-producing oligodendrocytes may be equally vulnerable to the impairments caused by Aβ and tau protein hyperphosphorylation. 2 White matter hyperintensities (WMHs) play a role in symptom presentation but are not core features of AD pathology. 3 Postmortem and in vivo magnetic resonance imaging (MRI) studies have substantiated recent hypotheses of white matter involvement in AD, finding reduced white matter volume and alterations of white matter microstructure. [4] [5] [6] Still, little is known about the relationship between Aβ pathology and myelin alteration. Recent advancements of cerebrospinal fluid (CSF) biomarkers show promise for early detection of AD pathology. Concentrations of specific proteins within CSF, such as Aβ42, total tau protein (Ttau), and phosphorylated tau 181 (Ptau181), are related to the core pathology of AD 7-9 and differentiate patients with AD from healthy, age-matched controls. 10 Cerebrospinal fluid biomarkers have additionally been linked to measures obtained with volumetric MRI and diffusion tensor imaging, suggesting that CSF biomarkers are sensitive to structural brain changes during the preclinical stages, onset, and progression of AD. 4 Relationships between CSF biomarkers and brain structure are increasingly important 4,11 ; however, while MRI techniques provide detailed anatomical and microstructural insight, they are influenced by a broad range of microstructural changes. 12 Thus, the biological interpretation of such associations is challenging. The breakdown of the myelin sheath may be an early phenomenon in AD, 5, 13 but more clinical studies are needed, especially in the preclinical stage. Recent quantitative MRI measures, such as longitudinal and transverse relaxation rates (R 1 and R 2 , respectively) and the myelin water fraction (MWF), may provide increased sensitivity to myelin content, 14, 15 and these may offer new insights regarding the role of myelin vulnerability in the pathogenesis of AD. Examining relationships between white matter measures and CSF biomarkers related to AD pathology-such as Aβ42 (reflecting cortical amyloid deposition), Ttau (as a marker for the intensity of neurodegeneration), and Ptau181 (correlating with tangle burden) 16 -could provide an appreciation for the extent and timing of myelinated white matter damage in AD. To our knowledge, no studies to date have explored such relations at the preclinical stage of AD. However, evidence of such relationships may support and transform the current understanding of the involvement of myelinated white matter and its alterations during the developmentofAD.
We report results from 71 late-middle-aged asymptomatic adults who underwent CSF collection via lumbar puncture 17 Table. sAPP-β was measured using the Meso Scale Discovery Multiplex Soluble APP assay according to the manufacturer's instructions. Board-certified laboratory technicians, blinded to clinical information, analyzed all samples according to protocols approved by the Swedish Board of Accreditation and Conformity Assessment. One batch of reagents was used yielding intra-assay coefficients of less than 10% variation.
MRI Data Acquisition and Processing
Participants were imaged ona3TGeneral Electric MR750 Discovery scanner (General Electric Healthcare) with an 8-channel receive-only head coil (Nova Medical). The mcDESPOT protocol included both spoiled gradient-recalled echo images and balanced steady-state free precession images acquired over multiple flip angles (eFigure 1 in the Supplement Age-related changes in R 1 ,R 2, and MWF were examined by fitting linear models at each brain voxel contained within a white matter mask (eFigure 2 in the Supplement). Each model examined R 1 ,R 2 and MWF as a function of age, while accounting for sex, APOE carrier status, log-transformed normalized WMH volume, and the Framingham cardiovascular risk score due to known effects on brain microstructure. 23 We examined education level and family history as additional nuisance variables; however, no significant relationships were observed by including these variables. Statistical maps were thresholded at a level of P < .05, corrected for multiple comparisons using the false discovery rate (FDR) 24 at the voxel level.
Relationships Between CSF Biomarkers and MWF Voxelwise linear regressions were fit to examine relationships between R 1 ,R 2, and MWF and concentration levels of CSF biomarkers. Individual CSF biomarkers, as well as biomarker ratios with Aβ42, were used as predictor variables, while age, sex, APOE status, Framingham cardiovascular risk score, and log-transformed normalized WMH volume were covariates. Analyses were constrained to white matter and the FDR corrected for multiple comparisons. After establishing significant findings between age and relaxometry measures as well as between R 1 ,R 2, and MWF and CSF biomarkers, we used additional models to examine whether concentrations of CSF biomarkers moderated the effect of age on the brain's MWF, R 1 , and R 2 . Predictors in these voxelwise models included age, CSF biomarker concentration, and the interactions of CSF biomarker concentration with age, as well as the covariates of sex, APOE, log-transformed normalized WMH volume, and Framingham cardiovascular risk score. 
Results

Changes in CSF Biomarkers and Imaging Measures With Age
Age at time of lumbar puncture was not significantly associated with CSF biomarkers (Pearson correlations shown in eTable 1 in the Supplement). Widespread age-related changes (P < .05, FDR corrected) were observed, particularly in late myelinating brain regions such as frontal white matter and the genu of the corpus callosum ( Figure 1 ). Myelin water fraction was negatively related to age, suggesting an overall decrease in myelin content with aging. R 1 decreased in similar brain regions, including frontal white matter and the genu of the corpus, while R 2 decreased with age across most white matter. Summary information is provided in eTable 2 in the Supplement. These findings suggest alterations to microstructural white matter and perhaps specifically in myelin content; however, such changes may be a result of increases of bulk water content or other biologically based changes.
25 Such findings are consistent with reported literature of age-related declines of white matter during typical and atypical aging.
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Relationships Between CSF Biomarkers and Imaging Measures
Voxelwise regressions between CSF biomarkers and imaging measures revealed widespread and robust main effect associations. Lower Aβ42 was associated with decreased MWF, R 1 , .05
A, Significant (P < .05, false discovery rate [FDR] corrected) age-related relationships with myelin water fraction (MWF) (top row), R 1 (middle row), and R 2 (bottom row) overlaid on the group mean MWF map. Negative relationships were observed across widespread white matter, with late myelinating areas, including frontal and temporal white matter, having the strongest age-related declines. B, representative scatterplot depicts the mean MWF, R 1 , and R 2 calculated from areas of significant age decline plotted against the age of each participant. Scatter points represent individual mean parameter (MWF, R 1 , and R 2 ) values and the solid trend line represents the line of best fit with age.
and R 2 .R 2 displayed the most extensive relationships, followed by MWF and R 1 (eTables 3-5 in the Supplement). Relationships were primarily located within the left hemispheric angular gyrus white matter for MWF and R 1 , while associations with R 2 were found across the left hemispheric temporal and parietal white matter and inferior longitudinal fasciculus. Other less localized white matter regions were additionally implicated (eFigure 3 in the Supplement). We observed significant negative relationships (P<.05, FDR corrected) between MWF, R 1, and R 2 and CSF biomarkers of Ttau, Ttau/Aβ42, Ptau181, Ptau181/Aβ42, sAPPβ, and sAPPβ/Aβ42. Representative findings between MWF and sAPPβ/Aβ42 are shown in Figure 2 while relationships between MWF, R 1 , and R 2 and other CSF biomarkers are shown in eFigures 4-6 in the Supplement. We highlight the negative association between MWF and sAPPβ/Aβ42 in representative scatterplots in Figure 3 . Relationships with MWF were extensive across white matter and discovered in the frontal, temporal, parietal, and cerebellar white matter. Soluble amyloid precursor protein/Aβ42 showed the strongest effect with regions known to be preferentially affected by AD, including temporal and frontal white matter, the body of the corpus callosum, and the cingulum. 27 We found negative relationships between CSF biomarkers and R 1 in the cingulum, inferior fronto-occipital fasciculus, and the superior longitudinal fasciculus, with extensive relationships occurring with sAPPβ/Aβ42. We also observed negative associations with R 2 , with relations between R 2 and Ptau181/Aβ42 having the largest impact.
CSF Biomarkers Moderate Myelin Content Age Relationships
We observed significant (P < .05, FDR corrected) ageby-biomarker interactions. In particular, we found relationships between MWF and Ptau181/Aβ42 in left hemispheric superior frontal gyral white matter and portions of the left superior longitudinal fasciulus in which higher levels of Ptau181/Aβ42 resulted in an increased MWF decline with age ( Figure 4 ). We provide a summary and depiction of the interaction results in eTable 6 and eFigure 7 in the Supplement.
Discussion
Alzheimer disease disrupts critical metabolic processes that ultimately lead to neurodegeneration; however, the effect of AD pathology on white matter-especially myelin-is still incompletely characterized. Using CSF biomarkers of AD together with quantitative relaxometry measures in cognitively asymptomatic middle-aged adults enriched for AD risk, we have demonstrated significant associations between AD pathology and measures of myelin health in vivo. Elevated concentrations of Ttau, Ptau181, and sAPPβ-along with elevated ratios of Ttau/Aβ42, Ptau181/Aβ42, and sAPPβ/Aβ42-were robustly associated with decreased MWF, R 1 , and R 2 across widespread brain regions. The effect of age on the trajectory of MWF was moderated by ratios of Ptau181/Aβ42 and Ttau/Aβ42, with elevated ratios leading to accelerated MWF decline. This is the first study, to our knowledge, to demonstrate relationships between AD pathology and relaxometry measures and further reinforce recent findings that AD pathology has an important impact on white matter microstructure.
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Our findings provide evidence that risk factors for developing AD are related to alterations of myelin content. Specifically, we find that age highly associates with MWF, R 1 , and R 2 decreases. These findings agree with studies showing white matter volume and microstructure to follow a negative gradient throughout later stages of life. Interestingly, we observed strong associations of decreased myelin content with increased ratios of sAPPβ and sAPPβ/Aβ42, with sAPPβ/Aβ42 having the greatest sensitivity. β-Amyloid is a product of amyloid precursor protein cleavage by β-secretase, which ultimately leads to the formation of amyloid plaques.
5 Animal studies using immunohistochemistry and electron microscopy on the triple-transgenic AD mouse, which harbors the amyloid precursor protein transgene, have found localized alterations in myelination and oligodendrocyte marker expression prior to the manifestation of amyloid and tau pathologies. 36 Findings from these previous studies in the context of the current study raise questions about the role of sAPPβ in myelin alterations of AD pathology. The remaining challenge of deciphering the causal mechanisms of these changes is determining if aberrant proteolytic processing of the amyloid precursor protein causes subsequent myelin damage or if degradation of myelin results in altered amyloid precursor protein processing. We need further animal and human studies to elucidate this causal pathway. Our findings also indicate that the strength of the relationship between MWF and age is altered by the ratios of Ptau181/ Aβ42 and Ttau/Aβ42. While tau pathology may follow amyloid pathology, hyperphosphorylation of tau protein also occurs during the repair of the myelin sheath.
5 Increased concentrations of Ttau and Ptau181 may reflect initial benefits to remyelination 5,13 and the effects of moderate myelin breakdown with aging. One hypothesis is that extensive timelimited repair and/or unsuccessful repair could lead to protein aggregation and deposition as neurofibrillary tangles.
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Limitations
This study has several limitations. First, while the sample provides a powerful cohort for investigating relationships of CSF biomarkers and brain microstructure, the enriched risk for AD (large percentage of family history positive-and APOE ε4-positive individuals), as well as the low percentage of males (19%), could limit the generalizability of our findings. Family history was found to have a nonsignificant effect on the findings of the current study. APOE status was included as a nuisance variable; however, it is possible that APOE allele status may impact brain aging 26, 28 and that future studies examining such relationships could be informative. Second, while qualitative agreement has been observed between mcDESPOT MWF and histology, 37 and strong evidence has been provided to support the application of mcDESPOT MWF, 29, 30, [38] [39] [40] future studies investigating the specificity and sensitivity of mcDESPOTderived MWF measurements compared with additional factorssuch as changes to brain volume, water content, iron load, or microstructural lipids and proteins-are necessary. While there was an overlap in findings with MWF, R 1 , and R 2 , associations in different brain structures between brain measures were also observed, suggesting that these measures are complimentary but may elucidate differential microstructural processes. 29 Last, cross-sectional analyses have permitted us to examine the associations between CSF biomarkers and neuroimaging measures. However, these findings should be explored in larger samples and extended in longitudinal samples to evaluate the time course of these relationships.
Conclusions
Myelin alterations in AD are suspected but understudied in human populations. Using a quantitative MRI technique sensitive to myelination, we measured CSF biomarkers and myelin content to examine the relationships between AD pathology. Our findings show, for the first time to our knowledge, that decreased concentrations of Aβ42 and elevated .05
A, Representative illustration of significant interactions of age and Ptau181/Aβ42 with MWF. Myelin water fraction from the peak voxel (as indicatedbythe cross-hair) was extracted and participants were subsequently split into 2 groups by the Ptau181/Aβ42 ratio median. B, Myelin water fraction was plotted and fit against participant age for each group. These plots demonstrate the changing age relationship with dissimilar Ptau181/Aβ42 ratio. 
